iBio, Inc. (62) | Development Agreements (2)
- Master Joint Development Agreement, dated as of August 8, 2018, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 19, 2020)
- Master Joint Development Agreement, dated as of August 8, 2018, between the Company and Beijing CC-Pharming Ltd (Filed With SEC on March 13, 2020)
